CN
Search...
About Us
Group Overview
Management Team
Milestones of Chipscreen
Group Honors
Social Responsibility
Core Technologies and R&D
Core Technologies
Scientific Committee
R&D System
Drug Lifecycle Management
Pipeline
Pipelines
News & Events
Company News
Media Coverage
Notices & Announcements
Video Library
Investors
Company Announcements
Periodic Reports
Career Development
Contact Us
Contact Details
CN
EN
News & Events
Chipscreen Highlights: Stay Updated on Recent Hot Topics
Home
News & Events
Company News
Media Coverage
Notices & Announcements
Video Library
Select year
2026
2025
2024
2023
2022
Earlier
shown/page
5
5
10
15
20
2017.03.27
Dr. Lu Xianping was invited to attend 2017 Asia Pacific Drug Research and Development Leader Summit
Dr. Lu Xianping was invited to attend 2017 Asia Pacific Drug Research and Development Leader Summit
Full text
2017.03.13
Chidamide won the most clinically valuable innovative medicine of the second China Pharmaceutical Innovative Brand in 2016
Chidamide won the most clinically valuable innovative medicine of the second China Pharmaceutical Innovative Brand in 2016
Full text
2017.01.05
Our company has won the national titles of " high-tech enterprise" and " Shenzhen high-tech enterprise"
Our company has won the national titles of " high-tech enterprise" and " Shenzhen high-tech enterprise"
Full text
2016.12.27
As a representative of Pingshan's innovation drive, our company was reported by Guangming net and other media
As a representative of Pingshan's innovation drive, our company was reported by Guangming net and other media
Full text
2016.11.29
Phase III clinical trial of Chiglitazar, a new CHIPSCREEN BIOSCIENCES anti-type 2 diabetes drug, completed
Phase III clinical trial of Chiglitazar, a new CHIPSCREEN BIOSCIENCES anti-type 2 diabetes drug, completed
Full text
06
07
08
...
16
Media contact
（+86）0755-36993500
pr@juliucq.com
